Discovery of Aminoacyl-tRNA Synthetase Mutants for the Incorporation of Non Canonical Amino Acids into Proteins by Tanrikulu, Ismet Çag˘ler
  
Discovery of Aminoacyl-tRNA Synthetase Mutants 











In Partial Fulfillment of the Requirements  
for the Degree of  







































İsmet Çağlar Tanrıkulu 
All Rights Reserved 
 iii 
Acknowledgements 
As it is for many, graduate school has been a long, convoluted journey for 
me as well.  Now that this part of my life is coming to a close, I realize more than 
ever the importance of so many people who helped me reach where I am right 
now. 
First and foremost I would like to thank my “experimental” advisor, Prof. 
David Tirrell, for his guidance and support for the past six years.  His patience in 
letting me carve my own research path, his willingness to learn about the details 
of my work, listen to the problems and discuss solutions, his genuine interest in 
understanding the principles behind the data on the screen all allowed me to 
learn a great deal on how to do science and how to have fun doing it.  My 
“computational” advisor, Prof. Bill Goddard, was extremely patient with me during 
the many years of failed binding-site designs, and always had countless ideas for 
the next step.  If it wasn’t for his encouragement for me to move on, I might have 
still been testing “dead” PheRS mutants until this day. 
I would like to thank the current and past members of my thesis 
committee, Profs. Harry Gray, Linda Hsieh-Wilson, Rich Roberts, and Vaidehi 
Nagarajan.  Our meetings occurred at critical times during my training.  Their 
interest in my work and questions they posed helped me reevaluate my research 
path in new light and greatly influenced the direction of research I pursued.  I 
very much appreciate their guidance. 
Perhaps the most difficult period in my PhD was after my first candidacy 
exam, which ended less than satisfactorily for most involved.  Prof. Judy 
Campbell, who was the BMB option head at the time, and Alison Ross, our 
option secretary, were both very supportive during this time and encouraged me 
in my quest to find a new research lab.  My conversations with Prof. Doug Rees, 
the chair of my first committee, helped me put all events in perspective.  Without 
their help I most likely would not be here today. 
My first introduction to both molecular biology and computer programming 
happened while I was working in the Pierce and Mayo labs.  I learned many 
fundamental molecular biology techniques from Rhonda Diguisto, who is a very 
 iv 
patient and organized teacher.  Shannon Marshall introduced me to circular 
dichroism, and Possu Huang was helpful with anything that went wrong in the 
lab, which, as some may know, is the norm rather than the exception.  As 
someone who did not have much programming experience I received a lot of 
help deciphering, modifying, and using the ORBIT code from Geoff Hom, Possu 
Huang, Dan Bolon, Robert Dirks, Shannon Marshall, Premal Shah, Deepshikha 
Datta, Eun Jung Choi, Jessica Mao, Kyle Lassila, and Marie Ary. 
The Tirrell lab, where I completed the experimental part of my PhD work, 
has provided me with a wonderful environment, both scientifically and socially.  I 
really doubt I will ever encounter such strong camaraderie again in the future.  A 
diverse set of skills are required for success in the Tirrell lab and I got introduced 
to many of these through Marissa Mock, Sarah Heilshorn, Jin Montclare, and 
Jamie Link.  However, I became confident with my lab skills only after receiving 
tremendous amounts of help from Inchan Kwon, with whom I shared both my lab 
bay and my office.  In addition to letting me use his endless knowledge on all 
types of procedures, Inchan also taught me how to design and pursue 
experiments, how to judge the factors affecting them, and above all, how to be 
consistent.  I deeply appreciate his help.  I was also fortunate enough to have 
many people around me to troubleshoot problems, to exchange ideas, or just to 
have a talk with in the lab.  Among these I have bothered Rebecca Connor, Tae 
Hyeon Yoo, Nick (J.D.) Fisk, John Ngo, Julie Champion, Ayae Sugawara, 
Makoto Ouchi, Soojin Son and Jin Montclare a countless times, and I thank them 
for their support and friendship.  Jamie Link was the person who first developed 
the screening strategy I describe and use in Chapter 2, and his assistance was 
very valuable to me as I was starting up.  Nick Fisk, Jamie Link, John Ngo and 
Mark van Eldijk allowed me to use reagents they had synthesized.  Inchan Kwon 
and Tae Hyeon Yoo offered me advice and assistance on flow cytometry and 
library screening in general, and, with Marissa Mock, helped me with the 
32PPi-exchange assays.  The MetRS-SLL x-ray crystal structure was obtained 
through a collaboration initiated by Tae Hyeon Yoo, with Yves Mechulam and 
Emmanuelle Schmitt and made many of the analyses presented here possible.  
 v 
Finally I would like to thank John Ngo for turning the results of what was originally 
an intellectual exercise into an exciting tool for cell-specific metabolic labeling. 
I performed the computational part of my PhD work in the Goddard lab, 
which contains an immense amount of expertise.  The two people in the group 
who had the biggest impact on me were Vaidehi Nagarajan and Ravi Abrol.  
Vaidehi taught me the basics of all the computational work I present here.  Her 
patience while working with me on the difficult problems and her encouragement 
kept me moving forward even when chances of success seemed bleak.  I also 
learned a lot from Ravi, who has the amazing ability divide large problems into 
logical, manageable chunks.  His guidance enabled me to obtain the results I 
now present in this work.  I was lucky to have access to such great mentors.  My 
work in the group involved the use of many newly introduced computational 
techniques, which required me to work closely with a number of people.  David 
Zhang, who created the COP strategy for binding site design, helped me greatly 
as I was getting started in the group.  Victor Kam‘s side chain placement 
procedure (SCREAM) was integral to my design strategy from the start, and he 
was always available for my questions and requests.  My meetings with Pete 
Kekenes-Huskey were always intellectually stimulating, whether they were about 
rotamer generation or binding calculations.  I really hope his torsional sampling 
code finds the audience it deserves.  Jonas Oxgaard and Julius Su helped me 
out whenever my QM calculations got stuck.  Andres Jaramillo-Botero was very 
understanding with my time constraints when I had to work on our ligand docking 
code and my thesis at the same time.  Finally, it has always been very gratifying 
to see my code being used by the group, and therefore, I also would like to thank 
the users of various programs I have written through the years.  
At Caltech, we are lucky to have an amazing staff to help us get through 
the day.  Alison Ross (BMB), Carol Mann and Anne Horman (Tirrell lab), and 
Shirley Feng (Goddard lab) have worked with me through many scheduling and 
administrative problems that came up.  Suresh Ghupta (ChE) and Darryl Willick 
(Goddard lab) have provided solutions to my computer related problems over 
and over and over again.  Haick Issaian, with Karen Baumgartner and other 
 vi 
EHSS staff, answered countless questions on radiation use and helped me 
locate reagents and working instruments when I needed them.  Mona Shahgholi 
trained me, helped me run MALDI and LC-MS measurements, and helped 
troubleshoot problems.  In addition to research-related staff, I also would like to 
thank all the people on campus, from Jim Endrizzi and Athena Trentin (ISP) to 
Tess Legaspi (Registrar’s office), from the health center staff to the pizza guys at 
Chandler, for keeping life at Caltech easy for us. 
It would have been impossible for me to live through years of failed 
experiments if it wasn’t for the love and support I received from my friends and 
family.  In addition to ones I’ve already mentioned, the Turkish community at 
Caltech, especially Ozgun Konca, Sirin Caliskan, Can Aydiner, Baris Bingol, 
Arkadas Ozakin, Ercan Gurses, Omer Durak, Ersen Bilgin and Grace Song, and 
Muruvvet Buyukboyaci have been a great source of support for me, day in and 
day out.  I thank Sarina Mohanty for constantly checking on me during the 
preparation of my thesis, and to Jose Navarette and Ozgun Konca for playing 
music with me from time to time.  Although I am yet to determine whether she 
was a blessing or a curse, Eun Jung Choi was there for me during most of my 
stay at Caltech and deserves credit for her assistance and support. 
My parents have always encouraged me to ask questions about anything 
and everything since I started talking, even if this would cause problems once in 
a while.  They did everything for me to get a good education, and it seems to 
have worked.  I have been away from home for the most part in the last two 
decades, and during this time they always made sure I knew they were there for 
me.  In this past year, during the preparation of this thesis, I felt their presence 
even stronger.  I am forever grateful for their love, care and support. 
At last, I would like to thank Julie Champion, John Ngo, Ravi Abrol, Shelly 
Tzlil, Grace Song and Prof. David Tirrell for all the time they spent reviewing and 




Efficient in vivo incorporation of a noncanonical amino acid into proteins 
often requires engineering new aminoacyl-tRNA synthetase (AARS) activity into 
the cell, usually by modifying a natural aaRS.  Although experimental methods, 
relying on mutagenesis and library screening, have identified many successful 
mutant aaRS-substrate pairs in the recent years, computational approaches have 
reported only a few successes.  Here we compare the results of computational 
and experimental screens of an E. coli methionyl-tRNA synthetase (MetRS) 
saturation-mutagenesis library for binding (in silico), and activation and cell-
surface display (in vivo) of azidonorleucine (Anl). 
Three positions (L13, Y260, and H301) in the methionine binding pocket of 
E. coli MetRS were randomized, and the resulting library was screened for 
MetRS activity toward Anl, based on a screening strategy previously established 
in our group.  This strategy relies on the introduction of reactive side chains into 
surface-exposed sites on outer-membrane protein C (OmpC), and their 
subsequent labeling with reactive, fluorescent probes.  We have discovered a 
large diversity of MetRS mutants that allow the incorporation of Anl into proteins 
in vivo.  The extent of OmpC expression and the amount of available Anl during 
the screen have substantial effects on the outcome of the screens.  In addition to 
displaying improved activities toward Anl, identified mutants also show an 
improved discrimination against Met.  We have shown that the degree of cell-
surface labeling in vivo correlates well with the measured rates of Anl activation 
in vitro, which reflects the success of the screen design.   
Computational analysis of the experimentally identified mutants revealed a 
good agreement between computed binding energies and in vitro activation data.  
To better test the computation model, we performed an in silico screen for Anl 
binding on a saturation-mutagenesis library comparable to the experimental 
library.  Computational screen predominantly selects mutants that interact with 
Anl through hydrogen bonds, whereas the hydrophobic residues are selected 
more often by the experimental screen.  We identify that experimental mutants 
try to optimize packing at the Y260 and H301 sites, but not at the L13 site.  We 
 viii 
discuss possible explanations for these results.  Combined results from 
computation and experiments suggest the importance of various factors in ligand 
recognition and in vivo selection of MetRS mutants.  We explore the implications 
of these factors to the future efforts in the engineering of new MetRS activities. 
 
 ix 
Table of Contents 
  Page 
Acknowledgements .......................................................................................... iii 
Abstract ............................................................................................................ vii 
Table of Contents ............................................................................................. ix 
List of Figures................................................................................................... xiv 
List of Tables .................................................................................................... xvii 
 
Chapter 1......................................................................................................... 1 
Introduction 
Role of Aminoacyl-tRNA Synthetases (AARS) in Cellular Protein Synthesis .. 2 
Incorporation of Noncanonical Amino Acids into Proteins ............................... 4 
Residue-specific Incorporation ......................................................................... 5 
Modification of AARS Activities ........................................................................ 7 
Computational Protein Design and Its Application to AARSs .......................... 10 
Discovery of MetRS Mutants Active Toward Azidonorleucine ....................... 11 
References ....................................................................................................... 13 
 
Chapter 2......................................................................................................... 20 
Discovery of E. coli Methionyl-tRNA Synthetase Mutants 
for Efficient In Vivo Labeling of Proteins with Azidonorleucine  
Introduction ...................................................................................................... 21 
Materials and Methods ..................................................................................... 23 
 Chemical reagents ...................................................................................... 23 
 Plasmids, cell strains, and cloning reagents................................................ 23 
 Methionyl-tRNA synthetase (MetRS) library construction........................... 24 
 OmpC overexpression...............................….............................................. 25 
 Cell-surface labeling.................................................................................... 25 
 Flow cytometry and cell sorting ................…............................................... 26 
 Recombinant DHFR expression, purification, and analysis ........................ 27 
 MetRS expression, purification, and in vitro activation assays ................... 28 
 x 
 
  Page 
Results and Discussion .................................................................................... 29 
 Construction of a MetRS saturation mutagenesis library............................ 29 
 OmpC overexpression and cell-surface labeling......................................... 30 
 Screening and identification of active mutants............................................ 32 
 Cell-surface labeling on cells bearing MetRS mutants................................ 35 
 Incorporation of Anl into recombinant proteins with MetRS mutants .......... 36 
 Incorporation of Anl through the MetRS-L13G mutant ............................... 37 
 In vitro activation kinetics for MetRS mutants ............................................. 38 
 Distribution of mutations at the randomized sites ....................................... 39 
 X-ray crystal structure of the Anl-bound MetRS-SLL mutant ...................... 41 
Conclusions...................................................................................................... 43 
Tables .............................................................................................................. 45 
Figures ............................................................................................................. 48 
References ....................................................................................................... 75 
 
Chapter 3......................................................................................................... 78 
Computational Modeling and Design of Methionyl-tRNA  
Synthetase Mutants for Activity Toward Azidonorleucine  
Introduction....................................................................................................... 79 
Materials and Methods ..................................................................................... 80 
 Simulation parameters ................................................................................ 80 
 Structure preparation .................................................................................. 81 
 Preparation of the Anl-MetRS complexes ..............…................................. 82 
 Binding-energy calculations ..............…...................................................... 84 
 Design of MetRS binding sites for Anl ........................................................ 86 
 Identification of low-fluorescence clones through library screening ........... 87 
 Characterization of the activities of MetRS variants toward Anl ................. 88 
 xi 
 
  Page 
Results and Discussion .................................................................................... 89 
 Discrimination of active MetRS variants among the Link et al. mutants: 
 The 2005 STUDY.......................................................................................... 89 
 Design of the MetRS binding site at three positions:  The LPY design 
 study ........................................................................................................... 90 
 Identification of MetRS mutants active toward Anl through library 
 screening in vivo ......................................................................................... 92 
 Implications of results from the experimental characterization to the 
 computational modeling of MetRS mutants ................................................ 93 
 Correlation between computational binding energies and activation  
 parameters of MetRS mutants for Anl:  The 2008 STUDY ........................... 94 
 Differentiation of highly active MetRS mutants from mutants of poor 
 activity ......................................................................................................... 96 
 Screening a saturation mutagenesis library in silico:  The LYH design 
 study ........................................................................................................... 96 
 Comparison of computed mutation distributions at the randomized 
 sites with experimental observations .......................................................... 99 
Conclusions...................................................................................................... 102 
Tables .............................................................................................................. 104 
Figures ............................................................................................................. 113 
References ....................................................................................................... 130 
 
Chapter 4 …..................................................................................................... 133 
Future Directions for the Discovery of New  
Methionyl-tRNA Synthetase Activities 
Ligand Recognition by Methionyl-tRNA Synthetase and Its Mutants .............. 134 
Selected MetRS Mutants May Display Broad Activities ................................... 136 
Creating a More Hydrophobic MetRS Binding Pocket ..................................... 137 
Proteomic Applications of MetRS-NLL ............................................................. 138 
 xii 
 
  Page 
Figures ............................................................................................................. 140 
References ....................................................................................................... 143 
 
Appendix A...................................................................................................... 144 
List of E. coli Methionyl-tRNA Synthetase Mutants Identified Through  
Library Screening to Show Activity Toward Azidonorleucine In Vivo 
 
Appendix B...................................................................................................... 148 
MALDI-MS Data Demonstrating the Incorporation of Azidonorleucine into  
Methionine Positions on Tryptic Fragments of Murine Dihydrofolate Reductase  
 
Appendix C...................................................................................................... 163 
Summary of Computational Design and Mutation Studies Performed on  
Aminoacyl-tRNA Synthetases Other than the Methionyl-tRNA Synthetase 
 Design of the E. coli isoleucyl-tRNA synthetase for the incorporation of 
 hexafluorovaline into proteins in vivo .......................................................... 163 
 Design of the E. coli valyl-tRNA synthetase for the incorporation of 
 hexafluorovaline into proteins in vivo .......................................................... 164 
 Designing the M. jannaschii tyrosyl-tRNA synthetase binding site for  
 tyrosine analogs.......................................................................................... 164 
 Designing the E. coli phenylalanyl-tRNA synthetase for the  
 incorporation of p-acetyl phenylalanine into proteins in vivo ...................... 166 
 Designing the S. cerevisiae phenylalanyl-tRNA synthetase for the  
 incorporation of cyano-phenylalanine into proteins in vivo ......................... 167 
 Introduction of  E. coli–like mutations into S. cerevisiae PheRS to  
 achieve in vivo incorporation of 2-quinoxalinylalanine ................................ 167 
 Tables and Figures......................................................................................169 
 References.................................................................................................. 176 
 xiii 
 
  Page 
Appendix D...................................................................................................... 178 
List of Software Written for and Used in the Modeling, Design, and Study 
of Methionyl-tRNA Synthetase Variants  
 xiv 
List of Figures 
Figure  Page 
2.1 Chemical structures of amino acids and tagging reagents.................... 48 
2.2 Protocol for screening the MetRS library for activity toward 
 azidonorleucine ..................................................................................... 49 
2.3 Four residues considered for saturation mutagenesis in the 
 methionine binding pocket of the E. coli MetRS .................................... 50 
2.4 Effect of OmpC overexpression on cell viability .................................... 51 
2.5 Effect of the duration of OmpC expression on the cell-surface 
 labeling of E. coli bearing the MetRS L13G mutant .............................. 52 
2.6 Fluorescence histograms outlining the progression of the library  
 selection ................................................................................................ 55 
2.7 Progression of the library selection where clones were selected for  
 Anl incorporation in the presence of 20 canonical amino acids ............ 56 
2.8 Extent of fluorescence labeling on cells bearing various MetRS  
 mutants at different of Anl concentrations ............................................. 57 
2.9 Expression of DHFR in cells bearing MetRS mutants at varying 
 concentrations of Anl ............................................................................. 59 
2.10 Mass spectra of a tryptic peptides from DHFR expressed in the 
 presence of the MetRS-L13G mutant ................................................... 61 
2.11 Response of fluorescence labeling to increasing Met concentration 
 in media containing 1.0 mM Anl ............................................................ 62 
2.12 Comparison of in vitro activation kinetics between MetRS mutants 
 identified through library screening ....................................................... 63 
2.13 Correlation between MetRS activation parameters for Anl and 
 EC50 values obtained from cell-surface labeling experiments ............. 66 
2.14 Distribution of mutations selected at each randomized site on 
 MetRS ................................................................................................... 67 
2.15 Comparison of the amino-acid binding sites of the ligand-bound 
 crystal structures of MetRS-SLL and wild-type MetRS ......................... 69 
 xv 
 
Figure  Page 
2.16 Comparison of the ligand-bound and unbound structures of  
 wild-type MetRS and the MetRS-SLL mutant ....................................... 71 
 
3.1 Structures of the E. coli methionyl-tRNA synthetase (MetRS)  
 active site and the ligands studied ........................................................ 113 
3.2 Complex preparation and optimization scheme .................................... 115 
3.3 The model for the Anl-bound MetRS-L13G mutant ............................... 116 
3.4 Distribution of binding energies for mutants evaluated in the  
 LPY design study................................................................................... 118 
3.5 Expression of DHFR in the presence of Anl in cells bearing  
 MetRS mutants identified from the LPY design study ........................... 119 
3.6 Screening for and characterization of a population of clones  
 displaying low cell-surface fluorescence ............................................... 120 
3.7 Correlation between Anl activation parameters and computed  
 Anl-binding energies for MetRS mutants............................................... 122 
3.8 Distribution of binding energies for mutants evaluated in the  
 LYH design study .................................................................................. 124 
3.9 Models for the best MetRS mutants in the in vivo and in silico 
 screens complexed with Anl .................................................................. 126 
3.10 Organization of water molecules around residue S13 .......................... 128 
3.11 Comparison of mutation distributions at each randomized site  
 between the in vivo and in silico screens............................................... 129 
 
4.1 Structures of natural and noncanonical methionine analogs ................ 140 
4.2 Expression of DHFR in the presence of Enl in cells bearing  
 various MetRS mutants ......................................................................... 141 
4.3 Interactions of a conserved water molecule in the MetRS  
 binding site ............................................................................................ 142 
 xvi 
 
Figure  Page 
B.1 Expression levels of DHFR at different media compositions ................ 150 
B.2 SDS-PAGE analysis of DHFR induced at different media  
 compositions and purified ..................................................................... 151 
B.3 Mass spectrometric analysis of tryptic fragments of DHFR  
 purified from cells bearing various MetRS variants ............................... 152 
C.1 Comparison of the T. thermophilus IleRS and ValRS binding sites ...... 171 
C.2 Randomized positions in the Mj-TyrRS binding site and the 
 ligands studied ...................................................................................... 172 
C.3 Comparison of Mj-TyrRS models bearing mutations identified by  
 experiments with double mutants received from the COP design  
 procedure .............................................................................................. 173 
C.4 The homology model of the S. cerevisiae PheRS ................................ 175 
 
 xvii 
List of Tables 
Table  Page 
2.1 Sequences for primers discussed in this chapter .................................. 45 
2.2 MetRS mutants identified in clones showing the highest 
 fluorescence labeling library screens .................................................... 46 
2.3 Kinetic parameters for the activation of Met and Anl by MetRS 
 mutants.................................................................................................. 47 
 
3.1 MetRS mutants tested for the incorporation of Anl into proteins by  
 Link et al. ............................................................................................... 104 
3.2 Sequences of primers discussed in this chapter ................................... 105 
3.3 Anl binding energies calculated for the Link et al. mutants in the  
 2005 STUDY ........................................................................................... 106 
3.4 Binding energies for the top 15 sequences from the LPY design 
 study ...................................................................................................... 107 
3.5 Kinetic parameters for the activation of Anl by mutants identified in  
 screens performed to isolate mutants with low activities ...................... 108 
3.6 Binding energies calculated for MetRS mutants with known  
 Anl-activation characteristics ................................................................. 109 
3.7 Revised Anl binding energies for Link et al. mutants in the  
 2008 STUDY ........................................................................................... 110 
3.8 Binding energies for the top 12 sequences out of 4,096 evaluated  
 in the LYH design study ........................................................................ 111 
3.9 Binding energies for the top 12 sequences out of 3,222 evaluated  
 in the LYH design study that do not interact with Anl through  
 hydrogen bonds .................................................................................... 112 
 
A.1 List of various populations that were obtained by screening  
 the LYH.1.0 library................................................................................. 145 
A.2 List of MetRS mutants identified through library screening to  
 activate Anl in vivo................................................................................. 146 
 xviii 
 
Table  Page 
C.1 List of aminoacyl-tRNA synthetase mutants tested in design studies  
 in this section......................................................................................... 169 
D.1 Software written for the study of MetRS mutants .................................. 179 
 
